General Biologic Group Ltd.

General Biologic: Your partner in growing bio-based businesses

General Biologic focuses on bio-business in China. We provide information products, management consulting, and transaction-based services for pharmaceutical companies, biotechnology companies, investors, and laboratory suppliers. China has made great advances in the quality and quantity of research work and in the development of its biotechnology industry. Its inevitable rise toward dominance in a number of bio-related services and manufacturing areas is already underway.

Opportunities for US, European and Japanese companies include:

• Substantially lowering the cost of discovery, development, tools, and services
• Accessing innovations by Chinese scientists
• Capitalizing on the growth of China’s market

GB understands the opportunities China presents. We help our clients create and implement strategies through the following areas of business:

• Information products: GB publishes reports critical for understanding China’s bio-business industry and the opportunities it presents
• Management consulting: GB provides China strategy, entry, partnership, valuation and due diligence services for clients
• Transaction services: GB helps clients with deal flow generation and capital raising services